← Back to Search

Emphasis on the Choosing Wisely Viral Prescription Pad for Infections

N/A
Waitlist Available
Led By Noah M Ivers, MD
Research Sponsored by Women's College Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Family physicians who sign up for the MyPractice reports by September 2021
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test whether adding viral prescription pad resources to existing antibiotic prescribing feedback reports will result in changes to antibiotic prescribing among primary care physicians in Ontario, Canada.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Antibiotic prescribing rate
Secondary outcome measures
Antibiotic drug costs
Antibiotics prescribed for viral infections
Proportion Antibiotic Rx with Prolonged Duration
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group - Viral prescription pad + emphasisExperimental Treatment1 Intervention
Physicians in this group will receive their usual MyPractice: Primary Care report from Ontario Health. This report will include antibiotic prescribing indicators as well as a link to the viral prescription pad. As part of the intervention, these physicians will also receive additional emphasis on the viral prescription pad by 1) encouraging it in the dissemination email of the MyPractice feedback report, and (2) mailing a paper version of the viral prescription pad with instructions on embedding the viral prescription pad into the recipient's EMR.
Group II: Control groupActive Control1 Intervention
Physicians in this group will receive their usual MyPractice: Primary Care report from Ontario Health. This report will include antibiotic prescribing indicators as well as a link to the viral prescription pad. This group will not receive any additional emphasis on the viral prescription pad and will not receive a paper copy in the mail.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Emphasis on the Choosing Wisely Viral Prescription Pad
2021
N/A
~3380

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,340 Previous Clinical Trials
26,449,319 Total Patients Enrolled
24 Trials studying Infections
235,021 Patients Enrolled for Infections
Ontario Agency for Health Protection and PromotionOTHER_GOV
9 Previous Clinical Trials
19,814 Total Patients Enrolled
Women's College HospitalLead Sponsor
100 Previous Clinical Trials
35,424 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts ongoing for this research endeavor?

"Clinicaltrials.gov reveals that applications for this trial are no longer being accepted, as the last edition occured on January 12th 2022. However, 39 other clinical trials have recently opened up recruitment opportunities."

Answered by AI
~1014 spots leftby Apr 2025